Ngā hua rapu - David S. Paterson

Whakamahine hua
  1. 1
    Defining the neurocircuitry of exercise hyperpnoea

    Defining the neurocircuitry of exercise hyperpnoea mā David J. Paterson

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)

    Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) mā David L. Paterson

    I whakaputaina 2000
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Impact of Antibiotic Resistance in Gram‐Negative Bacilli on Empirical and Definitive Antibiotic Therapy

    Impact of Antibiotic Resistance in Gram‐Negative Bacilli on Empirical and Definitive Antibiotic Therapy mā David L. Paterson

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species

    The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species mā David L. Paterson

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    “Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

    “Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy mā David L. Paterson

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The Role of Antimicrobial Management Programs in Optimizing Antibiotic Prescribing within Hospitals

    The Role of Antimicrobial Management Programs in Optimizing Antibiotic Prescribing within Hospitals mā David L. Paterson

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Neuromodulators of peripheral cardiac sympatho‐vagal balance

    Neuromodulators of peripheral cardiac sympatho‐vagal balance mā Neil Herring, David J. Paterson

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    ENCEPHALITIS CAUSED BY HUMAN HERPESVIRUS-6 IN TRANSPLANT RECIPIENTS

    ENCEPHALITIS CAUSED BY HUMAN HERPESVIRUS-6 IN TRANSPLANT RECIPIENTS mā Nina Singh, David L. Paterson

    I whakaputaina 2000
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Carbapenemase-Producing Enterobacteriaceae

    Carbapenemase-Producing Enterobacteriaceae mā David L. Paterson, Yohei Doi

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Invasive Aspergillosis in Transplant Recipients

    Invasive Aspergillosis in Transplant Recipients mā David L. Paterson, Nina Singh

    I whakaputaina 1999
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients

    Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients mā Yuki Hayashi, David L. Paterson

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Setting and Revising Antibacterial Susceptibility Breakpoints

    Setting and Revising Antibacterial Susceptibility Breakpoints mā John Turnidge, David L. Paterson

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    <i>Aspergillus</i>Infections in Transplant Recipients

    <i>Aspergillus</i>Infections in Transplant Recipients mā Nina Singh, David L. Paterson

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Interactions Between Tacrolimus and Antimicrobial Agents

    Interactions Between Tacrolimus and Antimicrobial Agents mā David L. Paterson, Nina Singh

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Detection of plasmid-mediated class C β-lactamases

    Detection of plasmid-mediated class C β-lactamases mā Yohei Doi, David L. Paterson

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative Bacilli

    A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative Bacilli mā David L. Paterson, Yohei Doi

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig <i>in vitro</i>

    Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig <i>in vitro</i> mā Neil Herring, David J. Paterson

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections

    Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections mā Marco Falcone, David L. Paterson

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Antibiotics in the clinical pipeline in October 2019

    Antibiotics in the clinical pipeline in October 2019 mā Mark S. Butler, David L. Paterson

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control

    Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control mā Alexander L. Green, David J. Paterson

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: